Valuation: Q-linea AB

Market Cap 313M 32.14M 28.26M 26.3M 24.16M 45.36M 3.08B 45.96M 122M 1.52B 121M 118M 5.26B P/E 2024
-0.37x
P/E 2025 -0.91x
Enterprise Value 60.39M 6.21M 5.46M 5.08M 4.67M 8.76M 595M 8.88M 23.59M 294M 23.31M 22.81M 1.02B EV / Sales 2024
49.8x
EV / Sales 2025 14.4x
Free-Float
86.04%
Yield 2024 *
-
Yield 2025 -
1 day+3.03%
1 week+1.19%
Current month-0.29%
1 month-3.41%
3 months-11.92%
6 months-38.00%
Current year-31.84%
1 week 16.1
Extreme 16.1
17
1 month 16.1
Extreme 16.1
19.2
Current year 14.55
Extreme 14.55
38.42
1 year 14.55
Extreme 14.55
64
3 years 14.55
Extreme 14.55
10,300
5 years 14.55
Extreme 14.55
164,000
10 years 14.55
Extreme 14.55
187,500
Manager TitleAgeSince
Chief Executive Officer 48 2025-10-18
Director of Finance/CFO 57 2026-06-14
Director of Finance/CFO 62 2017-12-31
Director TitleAgeSince
Director/Board Member 55 2024-02-29
Chairman 64 2017-12-31
Director/Board Member 57 2020-05-25
Date Insider Type Main position Quantity % Market Cap.
11/21/25 Buy

Chairman

4,000 0.0207%
11/12/25 Fiscal year

Chief Executive Officer

35,400 0.1833%
11/11/25 Buy 3,000 0.0155%
Change 5-day change 1-year change 3-year change Capi.($)
+3.03%+1.19%-65.24%-99.71% 32.23M
-3.03%-9.73%+11.64%-42.67% 15.54B
+4.07%+9.27%+1.83%+92.76% 1.65B
+5.39%+2.62%-34.78%-80.35% 1.09B
+1.20%-4.74%-39.37%+10.87% 948M
+3.70%-2.12%-43.46%-54.33% 609M
+1.10%-4.29%-50.51%-58.91% 505M
+0.27%+3.48%+39.11%-52.24% 460M
+1.49%-2.55%-56.75%-61.14% 365M
+1.29%-4.70%-21.48%-34.35% 344M
Average +2.02%-2.37%-25.90%-38.01% 2.15B
Weighted average by Cap. -0.78%-6.76%+2.06%-33.06%

Financials

2024 2025
Net sales 4.14M 426K 374K 348K 320K 600K 40.81M 608K 1.62M 20.15M 1.6M 1.56M 69.64M 15.28M 1.57M 1.38M 1.29M 1.18M 2.22M 151M 2.25M 5.97M 74.41M 5.9M 5.77M 257M
Net income -217M -22.3M -19.6M -18.25M -16.76M -31.46M -2.14B -31.88M -84.7M -1.06B -83.7M -81.89M -3.65B -182M -18.76M -16.49M -15.35M -14.1M -26.48M -1.8B -26.82M -71.27M -888M -70.43M -68.91M -3.07B
Net Debt 126M 12.91M 11.35M 10.56M 9.7M 18.21M 1.24B 18.45M 49.03M 611M 48.45M 47.41M 2.11B -252M -25.93M -22.8M -21.22M -19.49M -36.6M -2.49B -37.08M -98.52M -1.23B -97.35M -95.26M -4.24B
Logo Q-linea AB
Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.
Employees
70
Date Price Change Volume
26-07-27 SEK 17.00 +3.03% 7,372
26-07-24 SEK 16.50 +0.30% 13,950
26-07-23 SEK 16.45 -0.30% 1,633
26-07-22 SEK 16.50 -0.60% 9,472
26-07-21 SEK 16.60 -1.19% 721

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QLINEA Stock